0000899243-20-007719.txt : 20200310 0000899243-20-007719.hdr.sgml : 20200310 20200310141004 ACCESSION NUMBER: 0000899243-20-007719 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200306 FILED AS OF DATE: 20200310 DATE AS OF CHANGE: 20200310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DArecca James CENTRAL INDEX KEY: 0001583903 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36867 FILM NUMBER: 20700956 MAIL ADDRESS: STREET 1: 400 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allergan plc CENTRAL INDEX KEY: 0001578845 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CLONSHAUGH BUSINESS AND TECHNOLOGY PARK CITY: COOLOCK, DUBLIN STATE: L2 ZIP: D17 E400 BUSINESS PHONE: (216) 523-5000 MAIL ADDRESS: STREET 1: CLONSHAUGH BUSINESS AND TECHNOLOGY PARK CITY: COOLOCK, DUBLIN STATE: L2 ZIP: D17 E400 FORMER COMPANY: FORMER CONFORMED NAME: Actavis plc DATE OF NAME CHANGE: 20130930 FORMER COMPANY: FORMER CONFORMED NAME: Actavis Ltd DATE OF NAME CHANGE: 20130607 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-06 0 0001578845 Allergan plc AGN 0001583903 DArecca James CLONSHAUGH BUSINESS AND TECHNOLOGY PARK, COOLOCK, CO. DUBLIN L2 D17 E400 IRELAND 0 1 0 0 SVP Chief Accounting Officer Ordinary Shares, par value $0.0001 2020-03-06 4 F 0 718 191.95 D 9834 D Includes restricted stock units issued pursuant to the Amended and Restated 2013 Incentive Award Plan of Allergan plc. /s/ A. Robert D. Bailey, Attorney-in-Fact for the Reporting Person 2020-03-10